All publishers
Antonio Regalado
ReporterMIT Technology ReviewBeat: Artificial Intelligence, Robotics, Scientific Research, Clinical Trials, Drug Development, Pharmaceutical industry, Biological Aging
Observable, documented attributes only. We do not speculate about motives, private beliefs, or personality — patterns are shown with evidence.
Overall rating
Not yet rated. An author is rated after at least 5 of their claims have scored fact-check verdicts.
Bio
Antonio Regalado is a journalist who writes for MIT Technology Review.
Professional background
Not provided in supplied data.
Disclosed affiliations
MIT Technology Review
Sourcing patterns
Uses primary sources (TIER1_PRIMARY evidence) in his reporting.
Reporting vs. opinion history
Predominantly reporting; evidence-based coverage with minimal opinion.
Indexed articles
- Weight-loss drugs show signs of slowing biological aging, say drugmakers
Oct 6, 2026, 11:40 AM CDT